INSYS Therapeutics, Inc. filed second amended plan of liquidation with related disclosure statement in the US Bankruptcy Court on November 29, 2019. As per the amended plan filed, administrative Expense Claims is estimated to be $3.6 million, Convenience Class Claims of $2 million shall recover 10%. Trade and Other Unsecured Claims of $50 million, Insurance related claims of $258 million, Hospital Claims and NAS Monitoring Claims of $117 million shall recover 8.2%. DOJ Claims of $283 million shall recover 5.6%. State Claims and Municipality/ Tribe Claims of $597 million shall recover 8.3%. Personal injury claims shall be paid in full. There are no changes in the treatment of any other claim class. INSYS Therapeutics, Inc. filed modified second amended plan of liquidation in the US Bankruptcy Court on January 14, 2020. As per the amended plan filed, there is no change in treatment of any claim class.